Skip to content
Advertisement

In this Dec. 1, 2020, file photo the exterior of the European Medicines Agency is seen in Amsterdam, Netherlands. The European Medicines Agency is expected on Friday, Jan. 29, 2021 to authorize use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines. (AP Photo/Peter Dejong, File)

In this Dec. 1, 2020, file photo the exterior of the European Medicines Agency is seen in Amsterdam, Netherlands. The European Medicines Agency is expected on Friday, Jan. 29, 2021 to authorize use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines. (AP Photo/Peter Dejong, File)

Featured Photo Galleries